MOTS-c and SS-31 often end up in the same broad category of mitochondrial research, but they represent two very different experimental approaches.
MOTS-c: a mitochondrially encoded signalling peptide
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA region. The literature links it to retrograde signalling to the nucleus and regulation of responses to metabolic and cellular stress, including AMPK-related pathways.
PubMed review of MOTS-c mechanisms
SS-31: targeting the inner mitochondrial membrane
SS-31, also known as elamipretide in clinical development, is a synthetic tetrapeptide studied for its interaction with cardiolipin and the inner mitochondrial membrane. Mechanistic work describes binding to lipid membranes and changes related to bioenergetics and oxidative phosphorylation.
PubMed: SS-31 and mitochondrial membranes
Key difference
| MOTS-c | SS-31 | |
|---|---|---|
| Origin / type | Mitochondrially encoded peptide | Synthetic mitochondria-targeted tetrapeptide |
| Main research focus | Stress signalling, metabolism, AMPK and nuclear response | Cardiolipin, inner membrane, oxidative phosphorylation |
| Experimental logic | Signal between mitochondria and the rest of the cell | More direct membrane and bioenergetic context |
Why they are useful as comparative models
Both compounds fall under mitochondrial biology but target different layers of the same topic. Comparing their mechanisms therefore helps clarify the difference between mitochondrial signalling and more direct membrane/bioenergetic action.
Related profiles
See MOTS-c, SS-31 and the Mitochondrial biology collection.
This content is intended for research and educational context and does not constitute medical advice or instructions for use in humans or animals.